Evidence map›Paper›PMID 26180198›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

FGF Signaling Is Necessary for Neurogenesis in Young Mice and Sufficient to Reverse Its Decline in Old Mice.

Wenfei Kang, Jean M Hébert

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Tissue Engineered 3D Constructs for Volumetric Muscle Loss.Annals of biomedical engineering · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wenfei KangDepartments of Neuroscience and Genetics, Albert Einstein College of Medicine, Bronx, New York 10461.
Jean M HébertDepartments of Neuroscience and Genetics, Albert Einstein College of Medicine, Bronx, New York 10461 jean.hebert@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
Genetic Analysis of Forebrain Patterning & NeurogenesisR01MH070596 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HEBERT, JEAN M · 2006 to 2017
$3.9M
Assessing whether the adult neocortex can incorporate new projection neuronsR21NS088943 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HEBERT, JEAN M · 2014 to 2015
$459k
NCI NIH HHS P30 CA013330NCI NIH HHS P30CA013330NIMH NIH HHS MH070596NIMH NIH HHS R01 MH070596NINDS NIH HHS NS088943NINDS NIH HHS R21 NS088943
6 · The paper itself

Abstract

The mechanisms regulating hippocampal neurogenesis remain poorly understood. Particularly unclear is the extent to which age-related declines in hippocampal neurogenesis are due to an innate decrease in precursor cell performance or to changes in the environment of these cells. Several extracellular signaling factors that regulate hippocampal neurogenesis have been identified. However, the role of one important family, FGFs, remains uncertain. Although a body of literature suggests that FGFs can promote the proliferation of cultured adult hippocampal precursor cells, their requirement for adult hippocampal neurogenesis in vivo and the cell types within the neurogenic lineage that might depend on FGFs remain unclear. Here, specifically targeting adult neural precursor cells, we conditionally express an activated form of an FGF receptor or delete the FGF receptors that are expressed in these cells. We find that FGF receptors are required for neural stem-cell maintenance and that an activated receptor expressed in all precursors can increase the number of neurons produced. Moreover, in older mice, an activated FGF receptor can rescue the age-related decline in neurogenesis to a level found in young adults. These results suggest that the decrease in neurogenesis with age is not simply due to fewer stem cells, but also to declining signals in their niche. Thus, enhancing FGF signaling in precursors can be used to reverse age-related declines in hippocampal neurogenesis. SIGNIFICANCE STATEMENT: Hippocampal deficits can result from trauma, neurodegeneration, or aging and can lead to loss of memory and mood control. The addition of new neurons to the hippocampus facilitates memory formation, but how this process is regulated and how we might manipulate it to reverse hippocampal dysfunction remains unclear. The FGF signaling pathway has been hypothesized to be important, but its role in generating new neurons had been poorly defined. Our study indicates that FGF signaling maintains and expands subsets of neural precursor cells. Moreover, in older mice, increasing FGF signaling is sufficient to reverse the decline in neuron production to levels found in young adults, providing a potential means of reversing age-related hippocampal deficits.

Indexed as

AgingAnimalsCell CountDoublecortin Domain ProteinsFibroblast Growth FactorsGlial Fibrillary Acidic ProteinHippocampusKi-67 AntigenMiceMice, TransgenicMicrotubule-Associated ProteinsNestinNeural Cell Adhesion Molecule L1Neural Stem CellsNeurogenesisNeuronsDoublecortin Domain ProteinsFgfr1 protein, mouseFgfr2 protein, mouseFgfr3 protein, mouseFibroblast Growth FactorsGlial Fibrillary Acidic ProteinKi-67 AntigenMicrotubule-Associated ProteinsNestinNeural Cell Adhesion Molecule L1Neuropeptidespolysialyl neural cell adhesion moleculeReceptor, Fibroblast Growth Factor, Type 1Receptor, Fibroblast Growth Factor, Type 2Receptor, Fibroblast Growth Factor, Type 3Sialic Acidsagingdentate gyrusFGF receptorhippocampusmouseneurogenesis

Identifiers

PMID26180198
PMCPMC4502262
OpenAlexW1644276928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.